Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving viable micro-organism
Reexamination Certificate
2005-10-25
2005-10-25
Leary, Louise N. (Department: 1654)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving viable micro-organism
C435S034000, C435S287100, C435S283100
Reexamination Certificate
active
06958221
ABSTRACT:
The present invention is directed to a method for determining the effect of each of a plurality of test agents on cells from a subject, and a method to profile patient cell responses to test agents.
REFERENCES:
patent: 3772154 (1973-11-01), Isenberg et al.
patent: 3826899 (1974-07-01), Ehrlich et al.
patent: 4271123 (1981-06-01), Curry et al.
patent: 4343782 (1982-08-01), Shapiro
patent: 4632808 (1986-12-01), Yamamoto et al.
patent: 4676951 (1987-06-01), Armes et al.
patent: 4678752 (1987-07-01), Thorne et al.
patent: 4766078 (1988-08-01), Gang
patent: 5278048 (1994-01-01), Parce et al.
patent: 5320808 (1994-06-01), Holen et al.
patent: 5401629 (1995-03-01), Harpold et al.
patent: 5436128 (1995-07-01), Harpold et al.
patent: 5463564 (1995-10-01), Agrafiotis et al.
patent: 5541061 (1996-07-01), Fodor et al.
patent: 5556762 (1996-09-01), Pinilla et al.
patent: 5559002 (1996-09-01), Uzan et al.
patent: 5569588 (1996-10-01), Ashby et al.
patent: 5573909 (1996-11-01), Singer et al.
patent: 5574656 (1996-11-01), Agrafiotis et al.
patent: 5585275 (1996-12-01), Hudson et al.
patent: 5620894 (1997-04-01), Barger et al.
patent: 5630706 (1997-05-01), Yang
patent: 5633168 (1997-05-01), Glasscock et al.
patent: 5648219 (1997-07-01), MacKay et al.
patent: 5670113 (1997-09-01), Akong et al.
patent: 5804436 (1998-09-01), Okun et al.
patent: 5834196 (1998-11-01), Reutelingsperger
patent: 5919646 (1999-07-01), Okun et al.
patent: 6096509 (2000-08-01), Okun et al.
patent: 6242209 (2001-06-01), Ransom et al.
patent: 6280967 (2001-08-01), Ransom et al.
patent: 6558916 (2003-05-01), Veerapandian et al.
patent: 197 38566 (1999-03-01), None
patent: 0384740 (1990-08-01), None
patent: 0545284 (1993-06-01), None
patent: WO 90 04645 (1990-05-01), None
patent: WO 93 13423 (1993-07-01), None
patent: WO 96 30760 (1996-10-01), None
patent: WO 99/12041 (1999-03-01), None
patent: WO 00/20873 (2000-04-01), None
Arunlakshana, O. & Schild, H.O.,Brit. J. Pharmacol., vol. 14, pp. 48-58, 1959, “Some Quantitative Uses of Drug Antagonist”.
Berridge, et al.,Nature, vol. 341, pp. 197-205, 1989, “Inositol Phosphate and Cell Signaling”.
Berridge, M.J.,Nature, vol. 361, pp. 315-325, 1993, “Inositol Triphosphate and Calcium Signaling”.
Cheng, et al.,Biochem. Pharmacol., vol. 22, pp. 3099-3108, 1973, “Relationship Between the Inhibition Constant (Ki) and the Concentration of the Inhibitor Which Causes 50 Percent Inhibition (IC50) of an Enzymatic Reaction”.
Clapham, D.E.,Cell, vol. 80, pp. 259-268, 1995, “Calcium Signaling”.
Claudio, et al.,Science, vol. 239, pp. 1688-1694, 1987, “Genetic Reconstitution of Functional Acetycholine Receptor Channels in Mouse Fibroblasts”.
Divecha, et al.,Cell, vol. 80, pp. 269-278, 1995, “Phospholipid Signaling”.
Dunne, Time Window Analysis and Sorting, (1991), Cytometry 12:597-601.
Fagerstam, et al.,Journal of Chromatography, vol. 597, pp. 397-410, 1992, “Biospecific Interaction Analysis Using Surface Plasmon Resonance Detection Applied to Kinetic, Binding Site and Concentration Anaylsis”.
Gaddurn, J.H.,Pharmacol. Rev., vol. 9, pp. 211-218, 1957, “Theories of Drug Antagonism”.
Grynkiewicz, et al.,J. Biol. Chem., vol. 260, pp. 3440-3450, 1985, “A new generation of C2+Indicators With Greatly Improved Fluorescent Properties”.
Herskowitz, I.,Cell, vol. 80, pp. 187-197, 1995Kin, “MAP ase Pathways in Yeast: For Mating and More”.
Hill, et al.,Cell, vol. 80, pp. 199-211, 1995, “Transcriptional Regulation by Extracellular Signals: Mechanisms and Specificity”.
Lazareno, et al.,TIPS, vol. 14, pp. 237-239, 1993, “Estimation of Antagonist KbFrom Inhibition Curves in Functional Experiments: Alternatives to the Cheng-Prusoff Equation”.
Marshall, C.J.,Cell, vol. 60, pp. 179-185, 1995, “Specificity of Receptor Tyrosine Kinase Signaling: Transient Versus Sustained Extracellular Signal Regulated Kinase Activation”.
McConnell, et al.,Science, vol. 257, pp. 1906-1912, 1992, “The Cytosensor Microphysiometer: Biological Applications of Silicon Technology”.
Means, A.R.,FEBS Lett., vol. 347, pp. 1-4, 1994, “Calcium Calmodulin and Cell Cycle Regulation”.
Molecular Devices Corporation (1994) “Cytosensor Microphysiometer at Work Reference Guide”.
Molecular Devices Corporation (1996) “Cytosensor Microphysiometer.” ad.
Molecular Devices Corporation (1996) “Evaluating Receptor Desensitization using the Cytosensor Microphysiometer System”.
Nicotera, et al.,Cell Calcium, vol. 16, pp. 279-288, 1994, “Nuclear Calcium Transport and the Role of Calcium in Apoptosis”.
Ransom et al., AT1Angiotensin Receptors Mobilize Intracellular Calcium in a Subclone of NG108-15 Neuroblastoma Cells, (1992) Journal of Neurochemistry 58:1883-1888.
Ransom et al., Flow Cytometric Analysis of Internal Calcium Mobilization via a B2-Bradykinin Receptor on a Subclone of PC-12 Cells, (1991) Journal of Neurochemistry 56:983:989.
Ransom et al., Flow Cytometric Selection of Responsive Subclones and Fluorimetric Analysis of Intracellular Ca2+Mobilization (1994) Molecular Imaging In Neuroscience: A Practical Approach pp. 209-233.
Ransom et al., Flow Cytometric Systems for Drug Discovery and Development (2000), Optical Diagnostics of Living Cells III, D.L. Farkas and R.C. Lief eds. Proceedings of SPIE, vol. 3921, pp. 90-100.
Ransom et al., Isolation of Sublones With Enhanced Ca2+Response Homogeneity by Flow Cytometric Selection of Single Cells During a Ligand-Activated Ca2+Response, (1991) Methods A Companion to Methods in Enzymology vol. 2 No. 3 Jun. pp. 227-233.
Sakamoto, et al.,Biochem. Biophys. Res. Comm., vol. 200, pp. 679-686, 1994, “Pseudo-Noncompetitive Antagonism by BQ-123 of Intracellular Calcium transients Mediated by Human ETAEndothelin Receptor”.
Salon, et al.,Method of Neurosciences, vol. 25, pp. 201-224, 1995, “Real-Time Measurements of Receptor Activity: Applications of Microphysiometric Techniques to Receptor Biology”.
Sheng, et al.,Science, vol. 252, pp. 1427-1430, 1991, “CREB a Ca2+-Regulated Transcription Factor Phosphorylated by Calmodulin-Dependent Kinases”.
Sternweis, et al.,Trends Biol. Sci., vol. 17, pp. 502-506, 1992, “Regulation of Phospholipase C by G Proteins”.
Swiliens, et al.,TIPS, vol. 16, pp. 151-155, 1995, “Does a Radiolabeled Ligand Bind to a Homogenous Population of Non-Interacting Receptor Sites?”.
Weiland, et al.,Life Sciences, vol. 29, pp. 313-330, 1981, “Quantitative Analysis of Drug-receptor Interactions: 1. Determination of Kinetic and Equilibrium Properties.”Dunne, Time Window Analysis and Sorting, (1991), Cytometry 12:597-601.
Kaler Gregory
Veerapandian Pandi
Caliper Life Sciences, Inc.
Leary Louise N.
McKenna Donald R.
LandOfFree
Cell flow apparatus and method for real-time measurements of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cell flow apparatus and method for real-time measurements of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell flow apparatus and method for real-time measurements of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3448515